Navigation Links
EpiCept Corporation Announces Pricing of Public Offering
Date:12/4/2007

TARRYTOWN, N.Y., Dec. 4 /PRNewswire-FirstCall/ -- EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) announced today the pricing of a public offering of 3,333,333 million shares of its common stock at $1.50 per share and five-year warrants to purchase up to approximately 1,666,667 million shares of common stock at an exercise price of $1.50 per share. EpiCept will receive approximately $4.7 million in net proceeds from the offering. Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc. acted as placement agent. EpiCept intends to use the net proceeds for general corporate purposes.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020513/NYM112LOGO )

The public offering is being made pursuant to an effective registration statement. The public offering may be made only by means of a prospectus and prospectus supplement. A copy of the prospectus supplement relating to the common stock and warrants can be obtained from Rodman & Renshaw LLC, 1270 Avenue of the Americas, New York, NY 10020. An electronic copy of the prospectus and prospectus supplement will also be available on the website of the Securities and Exchange Commission at http://www.sec.gov.

This press release is neither an offer to sell, nor a solicitation of an offer to buy, nor shall there be any sale of, these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.

About EpiCept Corporation

EpiCept is focused on unmet needs in the treatment of pain and cancer. The Company's broad portfolio of pharmaceutical product candidates includes several pain therapies in clinical development and a lead oncology compound for AML with demonstrated efficacy in a Phase III trial; a marketing authorization applicatio
'/>"/>

SOURCE EpiCept Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. EpiCept Corporation to Present at the 2007 BIO InvestorForum
2. EpiCept to Present Preclinical Studies of EPC2407 in Combination With Anti-Angiogenic and Chemotherpeutic Agents at the AACR-NCI-EORTC International Conference
3. EpiCept Corporation To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
4. EpiCept To Host Third Quarter 2007 Conference Call and Webcast on November 7, 2007
5. EpiCept Corporation Reports Third Quarter 2007 Operating and Financial Results
6. EpiCept Corporation to Present at the BMO Capital Markets 2007 Focus on Healthcare Conference
7. Patient Enrollment Completed in Phase IIb Trial of EpiCept(TM) NP-1 in Diabetic Peripheral Neuropathy
8. EpiCept Announces Presentation of New Ceplene(TM) Data at the 49th Annual Meeting of the American Society of Hematology
9. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
10. Brooke Franchise Corporation Announces Selected July Results
11. MedThink Communications Retained by NanoBio Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... Raton, FL (PRWEB) June 19, 2013 At ... about the positive changes and growth that has occurred over ... nationwide travel club. , Shuman said, "Travel Services has added ... to heights beyond belief. Membership is up, even in ... to meet the demands of members." , Having been in ...
(Date:6/19/2013)... neuron disease Amyotrophic lateral sclerosis (ALS), also known as ... which can be classified into four distinct stages, report ... University of Pennsylvania in the Annals of Neurology ... cord tissues shows, for the first time, how the ... in the central nervous system to other regions of ...
(Date:6/19/2013)... molecule derived from a naturally occurring compound (apocynin), ... mice with Parkinson,s Disease symptoms by preventing deficits ... in the May 28, 2013 edition of ... Ph.D., postdoctoral fellow at the Medical College of ... paper. Balaraman Kalyanaraman, Ph.D., Harry R. & ...
(Date:6/19/2013)... Imprivata ®, a leading global provider of ... OneSign ® leads the single sign-on (SSO) category in ... Services report . CIOs and other healthcare executives iwere ... of its products and the quality of its customer ... integral to their long-term healthcare IT strategy. , ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 The US Food ... a third ultra cohesive gel breast implant, Mentor Worldwide’s MemoryShape™. ... 410 in February 2013. The FDA announced the approval of ... approved for primary augmentations in women 22 years ... any age. , The FDA’s approval comes after six ...
Breaking Medicine News(10 mins):Health News:Former Owner Eric Shuman Endorses New Owners and Changes Made in Last Year Since Shuman Sold Travel Services Center at Member Conference 2Health News:Staging system in ALS shows potential tracks of disease progression, Penn study finds 2Health News:Imprivata Tops Single Sign-On Category in KLAS 2013 Mid-Term Performance Review 2Health News:Imprivata Tops Single Sign-On Category in KLAS 2013 Mid-Term Performance Review 3Health News:FDA Approved Mentor® MemoryShape™ Breast Implants Now Offered to Patients at Swan Center for Plastic Surgery 2
... to the food chain via the Bernard Matthews plant, which ... in early February this year. , ,The Public ... turkey had to pass through the plant situated in Holton ... outbreak of the avian influenza and resumption of production services ...
... believe they may be on the right track ... key they say is stimulation of the occipital nerve. ... head and neck of the sufferers and giving them remotes ... reached separate research groups That included neurologists from the ...
... 8. According to statistics over one lac people Indians are ... cent die as they do not get timely treatment. ... Health Check-up package in connection with World Kidney Day-2007. The ... consultation and urine analysis for random glucose and creatinine. ...
... Want to de-stress, tone up your body or build your confidence? How ... and step on the dance floor// . ,'I tried going ... Then I started going for walks but I got bored of that ... stopped since,' said Suman Vohra, a doctor at the Apollo Hospital here. ...
... Implantable materials that grab stem cells and spur their ... and her colleagues// at MIT have created a new ... transplant environment--a key step in cell-transplant therapies. Scientists are ... well it can help heal fractures. ,"Creating ...
... schools and homes were housed under asbestos roofs. The children ... the repercussion of living their childhood days under asbestos roofs, ... cancer- Mesothelioma. Almost 5% of all lung cancers in the ... ,Mesothelioma is a medical term used to describe a cancer ...
Cached Medicine News:Health News:Doctors Put on Their Dancing Shoes to De-stress 2Health News:Healing Bone With Stem Cells 2
(Date:6/19/2013)... June 19, 2013 Today MedeAnalytics, a ... the next-generation of its Employer Group and ... plans to provide their employer groups an intuitive ... medical and prescription drug claims, network utilization, and ... http://photos.prnewswire.com/prnh/20100621/SF23660LOGO ) "Employer Group and ...
(Date:6/18/2013)... -- , Safinamide significantly improves responder ... add-on to levodopa Safinamide is associated ... fluctuating PD patients as add-on to levodopa ... a research and development company focused on novel ... S.p.A., a pharmaceutical company strongly committed to the ...
(Date:6/18/2013)... PROSPECT, Ill. , June 18, 2013 /PRNewswire-iReach/ ... of its new X3130 Appliance Inlet Module. The ... circuit breaker , combines a C14 appliance inlet ... one compact package.  This three-in-one device allows design ... their designs - cutting installation time by 66 ...
Breaking Medicine Technology:MedeAnalytics Introduces Next-Generation Employer Group and Individual Business Analytics Solution 2Safinamide Phase III Study Results Presented at 2013 MDS Meeting 2Safinamide Phase III Study Results Presented at 2013 MDS Meeting 3Safinamide Phase III Study Results Presented at 2013 MDS Meeting 4Safinamide Phase III Study Results Presented at 2013 MDS Meeting 5Safinamide Phase III Study Results Presented at 2013 MDS Meeting 6Three-in-One X3130 Appliance Inlet Module 2
... 2011 First Advantage , a ... solutions, today announced that it has made a significant ... The investment in Workstream was announced by Todd Mavis, ... is a supplier of talent acquisition and talent ...
... 20, 2011 Cardinal Health today announced that this ... show for independent pharmacies, is the largest in the ... This year,s event, taking place July 20-23 ... hotel, features a 100,000-square-foot trade show floor, highlighting buying ...
Cached Medicine Technology:First Advantage Invests in Workstream Inc. 2First Advantage Invests in Workstream Inc. 3Nearly 7,000 Participate in Cardinal Health's Largest-Ever Annual Trade Show for Independent Pharmacies 2Nearly 7,000 Participate in Cardinal Health's Largest-Ever Annual Trade Show for Independent Pharmacies 3Nearly 7,000 Participate in Cardinal Health's Largest-Ever Annual Trade Show for Independent Pharmacies 4
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: